CA1197512A - Preparation de derives cinnamamides substitues et produits obtenus - Google Patents
Preparation de derives cinnamamides substitues et produits obtenusInfo
- Publication number
- CA1197512A CA1197512A CA000426747A CA426747A CA1197512A CA 1197512 A CA1197512 A CA 1197512A CA 000426747 A CA000426747 A CA 000426747A CA 426747 A CA426747 A CA 426747A CA 1197512 A CA1197512 A CA 1197512A
- Authority
- CA
- Canada
- Prior art keywords
- cinnamoyl
- dimethyl
- oxazolidine
- acetone
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 18
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims abstract description 14
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- APEJMQOBVMLION-UHFFFAOYSA-N cinnamamide Chemical class NC(=O)C=CC1=CC=CC=C1 APEJMQOBVMLION-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 5
- 229910052736 halogen Chemical group 0.000 claims abstract description 4
- 150000002367 halogens Chemical group 0.000 claims abstract description 4
- 239000001257 hydrogen Substances 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 10
- PHODFIDDEBEGCS-UHFFFAOYSA-N 2,2-dimethylpyrrolidine Chemical compound CC1(C)CCCN1 PHODFIDDEBEGCS-UHFFFAOYSA-N 0.000 claims description 9
- 125000002391 4-chlorocinnamoyl group Chemical group 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 238000009833 condensation Methods 0.000 claims description 4
- 230000005494 condensation Effects 0.000 claims description 4
- VSHIRTNKIXRXMI-UHFFFAOYSA-N 2,2-dimethyl-1,3-oxazolidine Chemical compound CC1(C)NCCO1 VSHIRTNKIXRXMI-UHFFFAOYSA-N 0.000 claims description 3
- -1 cinnamoyl Chemical group 0.000 claims description 3
- 229940031098 ethanolamine Drugs 0.000 claims 5
- 150000001768 cations Chemical class 0.000 claims 2
- ZFOVCSTVYYYRSU-ZZXKWVIFSA-N (e)-3-(4-chlorophenyl)prop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=C(Cl)C=C1 ZFOVCSTVYYYRSU-ZZXKWVIFSA-N 0.000 claims 1
- GLBIKPKWQDIQCJ-ZZXKWVIFSA-N (e)-3-(4-fluorophenyl)prop-2-enoyl chloride Chemical compound FC1=CC=C(\C=C\C(Cl)=O)C=C1 GLBIKPKWQDIQCJ-ZZXKWVIFSA-N 0.000 claims 1
- WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 abstract description 2
- 229940035363 muscle relaxants Drugs 0.000 abstract description 2
- 239000003158 myorelaxant agent Substances 0.000 abstract description 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 description 3
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 2
- MADRVGBADLFHMO-UHFFFAOYSA-N Indeloxazine Chemical compound C=1C=CC=2C=CCC=2C=1OCC1CNCCO1 MADRVGBADLFHMO-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- MOQOOKGPCBQMCY-UHFFFAOYSA-N acetic acid;hexane Chemical compound CC(O)=O.CCCCCC MOQOOKGPCBQMCY-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8306075A FR2544311A2 (fr) | 1983-04-14 | 1983-04-14 | Forme medicamenteuse de theophylline a action prolongee |
| FR8306.075 | 1983-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1197512A true CA1197512A (fr) | 1985-12-03 |
Family
ID=9287831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000426747A Expired CA1197512A (fr) | 1983-04-14 | 1983-04-26 | Preparation de derives cinnamamides substitues et produits obtenus |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA1197512A (enrdf_load_stackoverflow) |
| FR (1) | FR2544311A2 (enrdf_load_stackoverflow) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2040181A1 (enrdf_load_stackoverflow) * | 1969-04-02 | 1971-01-22 | Lipha | |
| DE3361275D1 (en) * | 1982-05-04 | 1986-01-02 | Lipha | Sustained-release theophyllin drug formulation |
-
1983
- 1983-04-14 FR FR8306075A patent/FR2544311A2/fr active Granted
- 1983-04-26 CA CA000426747A patent/CA1197512A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2544311B2 (enrdf_load_stackoverflow) | 1985-04-19 |
| FR2544311A2 (fr) | 1984-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0202164B1 (fr) | Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique | |
| EP0049555B1 (fr) | Nouveaux dérivés de l'acide 2-trifluorométhyl-4-hydroxy-3-quinoline carboxylique et leur procédé de préparation | |
| EP0566468A2 (fr) | Procédé de préparation d'un dérivé de biphényl | |
| EP0325512B1 (fr) | Procédé de préparation d'alkyl-1 nitro-5 imidazoles | |
| EP0002978B1 (fr) | Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique | |
| CA1197512A (fr) | Preparation de derives cinnamamides substitues et produits obtenus | |
| EP0285500B1 (fr) | Urées substituées, leur procédé de préparation et leur application notamment dans l'ennoblissement des fibres cellulosiques | |
| EP0091851B1 (fr) | Procédé de préparation d'éthers d'aryle portant des substituants différents sur les deux noyaux aromatiques | |
| CA2162106C (fr) | Nouvelles 5-(aryloxymethyl)oxazolines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| CA1212111A (fr) | Procede de preparation de nouveaux derives du bicyclo¬4.2.0|octatrienne-1,3,5 | |
| EP0433267B1 (fr) | Préparation de l'acide éicosatétraynoique | |
| EP0363263B1 (fr) | Procédé de préparation de dérives de l'acide propionique | |
| EP1458724B1 (fr) | Synthese totale de la galanthamine, de ses analogues et de ses derives | |
| EP0685473B1 (fr) | Composés benzohétérocycliques, en tant qu'antioxydants | |
| CA1111447A (fr) | Composes halogenes, procede de preparation et application a la preparation du metaphenoxy benzaldehyde | |
| BE879730R (fr) | Derives d'alkylenediamines | |
| FR2505327A1 (fr) | Procede d'halogenation en meta de n-(o,o'-dialkyl phenyl) alaninates et homologues | |
| CA1184208A (fr) | Procede de preparation d'halogenoacetals ethyleniques | |
| EP0563219B1 (fr) | Procede de preparation de derives "syn" du propanamide | |
| EP0022710B1 (fr) | Procédé d'obtention de benzodiazépines-1,4 | |
| FR2670484A1 (fr) | Nouveau procede de monofonctionnalisation regiospecifique d'un hydroxy phenolique sur un polyphenol. | |
| EP0097550B1 (fr) | Procédé de préparation de dérivés de la cystamine à activité oncostatique | |
| FR2738825A1 (fr) | Procede de purification d'un 1,3-bis(3-aminopropyl)-1,1, 3,3-tetraorgano-disiloxane | |
| FR2641784A1 (fr) | Procede de preparation de derives du chromanne et intermediaires de synthese | |
| FR2465735A1 (fr) | Composes intermediaires pour la preparation de derives de la morphine, et leur procede de preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEC | Expiry (correction) | ||
| MKEX | Expiry |